In cases of drug-induced hepatotoxicity, dose adjustments, treatment discontinuation, or alternative therapies may be necessary
Rare, but serious, adverse events associated with the intravascular injection of soft-tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures
Administered at a dose of 360 mg/kg for 14 days, the extract markedly reduced IBA-1, IL-1, A1-42, and phosphorylated tau (p-tau) levels, highlighting its anti-inflammatory and neuroprotective properties (Wang Y
Many clinicians consider anti-obesity medications after the initial rapid weight loss phase, typically 6-12 months post-operatively, or when patients experience a plateau or weight regain despite adherence to post-surgical recommendations